Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy Against Triple-Negative Human Breast Cancer Cells
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-11-0979
Full Text
Open PDFAbstract
Available in full text
Date
February 24, 2012
Authors
Publisher
American Association for Cancer Research (AACR)